Considerable on MSN
GSK buys Rapt in $2.2B deal
GSK agreed to acquire Rapt Therapeutics for $2.2 billion on Tuesday, a move that ...
The Daily Overview on MSN
GSK grabs RAPT for $2.2B in big bet on food allergy drugs
GSK is staking billions on a new way to protect people from life‑threatening food allergies, agreeing to buy RAPT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results